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Intense inﬁltration of gastrointestinal and colonic mucosa with eosinophils or acidophilic gastroenteritis (EG) is a relatively
uncommonpicture for a pathologist endoscopist especially outside the pediatric age group and is highly suggestive of an ongoing
chronic inﬂammatory process. Existing literature projected a hypothetical association with allergy but the exact pathophysiology
is still unknown. Association with malabsorption, protein losing enteropathy, and refractory ulcers with gastrointestinal bleeding
makes the clinical presentation more complicated. We present a unique case of diarrhea and abdominal pain in the clinical
presentationwithassociatedperipheraleosinophilia,asthma,andgastroesophagealreﬂuxdisease(GERD).Thepatient’ssymptoms
abated after initiation of budesonide.
1.CaseReport
A 45-year-old white female reported to the emergency
department with chief complaints of abdominal pain and
shortness of breath. These symptoms were associated with
a 1-week history of nausea, vomiting, abdominal pain, and
diarrhea. The patient described the diarrhea as watery,
with a stool frequency of 10–20 movements daily, without
blood. The vomiting typically occurred within 15 minutes
of eating and was greenish with no evidence of blood. The
symptoms occurred the night after construction began at
her work place; she was a clerical postal service employee.
The construction appeared to trigger an asthma exacerba-
tion. She denied recent travel, sick contacts, consuming raw
seafood, fever/chills, or eating out. She denied any allergies
to medicines or foodstuﬀ. She had a past history of GERD
and asthma. She denied alcohol or recreational drug use but
she smoked 1-2 cigarettes a day for the past 6 years. Current
medications included Pantoperazole and Albuterol inhaler.
On physical examination, the patient was afebrile and
vitals were within normal limits. The patient had dry
mucous membranes. Abdominal exam revealed diﬀuse mild
tenderness. Complete blood count showed a white cell
count of 11.6 (nl 4.0–10.0). Complete metabolic panel was
within normal limits. Fecal occult blood was negative. Stool
culture for ova and parasites, C.diﬃcile toxin, leukocytes,
Salmonella, Shigella, Campylobacter, Yesinia, and E. Coli
0157:H7 were all negative. IgE mold allergens were also
negative. Serum IgE was within normal range. Peripheral
eosinophils were elevated with an absolute eosinophil count
peaking at 4.8 during hospital stay (NL 0–0.5k/mm3), and
computed tomography (CT) of the abdomen and pelvis
revealed no abnormalities or inﬂammation.
The patient was admitted under the working diagnosis
of gastroenteritis and treated with intravenous ﬂuids and
antibiotics. There was no improvement over the next 3-
day duration. Upper endoscopy and colonoscopy showed
signs of inﬂammation in the gastric antrum with no other2 ISRN Gastroenterology
Figure 1: Unremarkable cecal mucosa.
macroscopic evidence of inﬂammation in the upper and
lower gastrointestinal tract (Figure 1). Antral biopsy was un-
remarkable and negative for H. Pylori.S m a l lb o w e lb i o p s y
showed signs of inﬂammation with high level of eosinophilic
inﬁltrates (>15/hpf) (Figure 2). Even though the colon
appeared macroscopically unremarkable, random mucosal
biopsies showed microscopic pathology in the right and left
colon. There were greater than 15 eosinophils per high-
power ﬁeld in the colonic mucosal biopsy specimens. Rectal
biopsies were unremarkable. A diagnosis of eosinophilic
enterocolitis was made, and the patient was discharged with
conservative management with an outpatient clinic visit
within a week of discharge. Since the patient’s symptoms
persisted, a trial of budesonide was initiated which resulted
in complete resolution of her symptoms.
2.Discussion
Eosinophilic enterocolitis represents a subset of a broader
diseasegroupthatincludeseosinophilicesophagitis,gastritis,
enteritis,and colitis,commonlyreferred toastheeosinophil-
ic gastrointestinal disorders [1].
Eosinophilic gastroenterocolitis is an extremely rare
disease, with less than 200 patients described; the largest
published series includes only 40 patients [2, 3]. The ﬁrst
reported case was originally described by Kaijser in 1937, as
a rare spectrum of gastrointestinal disorders characterized
by inﬂammation rich in eosinophils without evidence of
a known cause for eosinophilia [4]. Currently, the mean
duration between symptom onset and diagnosis in patients
with eosinophilic gastroenteritis is 4.1 ± 5.7 years [5]. The
disease can aﬀect patients of any age, but is more com-
monly seen in the third through ﬁfth decades with a male
predominance [2, 6]. Eosinophilic gastroenteritis should be
considered when a patient presents with unexplained gas-
trointestinal symptoms that cannot be deﬁned by parasitic
or other gastrointestinal diseases. Diagnosis is deﬁned by
three criteria: (a) the presence of GI symptoms, (b) biopsies
showing eosinophilic inﬁltration of one or more areas of
the GI tract (or with characteristic radiological ﬁndings with
Figure 2: Eosinophilic inﬁltration.
peripheral eosinophilia), and (c) no evidence of parasitic or
extraintestinal disease [2].
A peripheral eosinophilia may be helpful but is not
necessarily a universal ﬁnding, and it may be absent in 20%–
90%ofcases[7, 8].Kleinsubdividedthedisease based onthe
extent of bowel wall most inﬁltrated by eosinophils: mucosa,
muscularis, and subserosa [9]. Due to the patchy inﬁltrate of
the disease throughout the GI tract, eosinophilic gastroen-
teritis cannot be ruled out even if all biopsies are negative.
In one study, 5 out of 40 endoscopic biopsies, missed the
eosinophilic inﬁltrate [2]. A study using CT to look for areas
o fi n ﬂ a m m a t i o n ,a sw e l la ss u r g i c a lf u l lt h i c k n e s sb i o p s i e s
may help localize areas for biopsies [10]. The most common
radiographic ﬁnding seen in eosinophilic gastroenteritis is
diﬀuse nodular and irregular fold thickening in the distal
stomach and in the proximal small bowel [11, 12].
The cause of eosinophilic gastroenteritis remains un-
known. Seventy-ﬁve percent of aﬀected patients have a his-
tory of allergy or atopy [5]. A case report demonstrated
accumulation of mast cells in the interstium of the colon
wall after immunohistochemical staining for the mast cell
enzyme tryptase suggesting the pathogenic role of IgE [13].
Another study showed possible pathogenesis involving the
eosinophilicchemoattractants inerleukin-5andeotaxin[14].
Therapy of eosinophilic gastroenteritis is limited to case
reportsandretrospectivestudies;therefore,withoutprospec-
tive and randomized therapeutic trials, treatment remains
purely empirical and based on clinical manifestations. An
empiric elimination diet, with the assistance of a dietitian
trained in eosinophilic GI disorders, may provide successful
treatment [15]. Chehade et al. reported that children who
were placed on an elemental diet showed a signiﬁcant
decrease in symptoms [16]. In more severe cases, oral
Prednisone (20–40mg/day), with a rapid taper, may provide
success. In one study involving 13 patients all had reported
successful resolution of symptoms within 2 weeks [15].
Other therapies have been tried including sodium chromo-
glycate, ketotifen [17], montelukast [18], and Th2 cytokine
inhibitor suplast tosilate [19]. However, their long-term
eﬀectiveness is questionable and requires more prospective
clinical trials. Foroughi and colleagues reported success inISRN Gastroenterology 3
an open-label study of nine patients treated with omal-
izumab, a monoclonal anti-IgE antibody [6]. Patients with
relapsingandrefractory diseaseareoftenplacedonlow-dose,
long-term steroids, or immunosuppressive therapy. Few
studieshavefollowedpatientswitheosinophilicgastroenteri-
tisforlongterm,butlong-termtreatment isoftenineﬀective.
In summary, Eosinophilic enterocolitis may represent an
underappreciated condition. The recognition of eosinophilic
enterocolitis constitutes a challenge to hospitalists, gastroen-
terologists, and the physician community at large.
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